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Abstract 
Background: Skeletal muscle atrophy is caused by a variety of diseases and conditions. In particular, skeletal mus-
cle atrophy in the elderly contributes to a loss of independence with advanced age and increases the risk of falling. 
However, the effect of food consumed on a daily basis on skeletal muscle atrophy has been the focus of little research. 
In this study, the effects of dietary supplementation with shiikuwasha extract or grape extract on dexamethasone-
induced skeletal muscle atrophy were evaluated in aged rats.
Methods: Aged male rats (15-month-old) were fed a diet supplemented with either 1 % shiikuwasha extract or 1 % 
grape extract for 19 days. During the last 5 days of the feeding period, rats were injected with dexamethasone to 
induce muscle atrophy.
Results: Body weight and hind-limb muscle weight were significantly decreased by dexamethasone treatment. The 
supplementation of shiikuwasha extract showed no effect on body weight loss, but markedly attenuated tibialis ante-
rior muscle weight loss induced by dexamethasone. On the other hand, grape extract did not affect muscle weight 
loss. Furthermore, shiikuwasha extract significantly reduced dexamethasone-induced expression of atrogin-1 and 
MuRF1 mRNA, but did not reduce LC3B-II protein levels.
Conclusion: These results suggest that shiikuwasha extract may partially inhibit the activation of the ubiquitin–pro-
teasome system and may consequently attenuate skeletal muscle atrophy induced by dexamethasone in aged rats.
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Background
Skeletal muscle atrophy is caused by a variety of diseases 
and conditions including malnutrition, disuse, sepsis, 
cachexia, and glucocorticoid excess. In particular, skel-
etal muscle atrophy in the elderly contributes to a loss of 
independence with advanced age and increases the risk 
of falling (Landi et  al. 2012); therefore, skeletal muscle 
atrophy is a very important problem in an aging society. 
Many pathological conditions that cause muscle atro-
phy, such as sepsis, cachexia and starvation, are associ-
ated with increases in circulating glucocorticoid levels 
(Schakman et al. 2008). Moreover, sepsis-induced muscle 
atrophy is attenuated by treatment with a glucocorticoid 
receptor antagonist (Fischer et  al. 2000). These results 
suggest that glucocorticoids are partly responsible for 
muscle atrophy under these conditions. In addition, mus-
cle atrophy induced by disuse is exacerbated by hypercor-
tisolemia (Fitts et  al. 2007); therefore, it is thought that 
many factors are involved in the progression of muscle 
atrophy.
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Glucocorticoids such as dexamethasone induce body 
weight loss, skeletal muscle atrophy, and acute insu-
lin resistance (Pagano et al. 1983; Ruzzin et al. 2005). In 
skeletal muscle, glucocorticoids induce selective loss of 
fast-twitch type-2 muscle fibers, and might not affect 
type-1 muscle fibers (Dekhuijzen et al. 1995). Ubiquitin- 
proteasome system and autophagy- lysosomal system 
play significant role in the protein degradation of muscle 
(Sandri 2013). It has been reported that both pathways 
are also activated during skeletal muscle atrophy induced 
by glucocorticoids, showing increased mRNA expres-
sion of muscle-specific ubiquitin E3 ligases, atrogin-1 
and MuRF1 (Auclair et al. 1997), and the lipidated form 
of LC3 (LC3-II) protein, which is known as marker of 
autophagy (Penna et al. 2013). Glucocorticoids also affect 
muscle protein synthesis. Glucocorticoids reduce mRNA 
expression of IGF-1, which promotes protein synthesis 
(Gayan-Ramirez et  al. 1999), and phosphorylated ribo-
somal protein S6 kinase 1 (S6K1), which is one of the 
regulators involved in the initiation of mRNA translation, 
in type-2 fiber rich muscles (Shimizu et  al. 2011). The 
responsiveness of muscle protein metabolism to gluco-
corticoids is known to be affected by age. Muscle protein 
synthesis stimulated by insulin or IGF-1 is inhibited by 
glucocorticoids more strongly in aged rats than in young 
rats (Dardevet et  al. 1998). In addition, glucocorticoid 
excess was observed to induce a prolonged leucine resist-
ance in muscle protein synthesis in aged rats (Rieu et al. 
2004). These results indicate that aging increases the sen-
sitivity to glucocorticoid-induced muscle atrophy.
Polyphenols, widely contained in fruits, have been 
reported to have various physiological effects. Shiikuwa-
sha (Citrus depressa Hayata) fruit contains many poly-
phenols, such as polymethoxylated flavones (Nogata et al. 
2006). Nobiletin (5,6,7,8,3′,4′-hexamethoxy flavone), a 
polymethoxylated flavone from citrus, and its demethyl-
ated metabolites have been reported to have many ben-
eficial effects, such as reduced oxidative stress (Lu et al. 
2010), improved insulin sensitivity (Lee et  al. 2010) and 
anti-inflammation (Lai et al. 2008). Grapes (Vitis vinifera) 
are also known to contain many polyphenols, including 
the stilbenoid resveratrol (Siemann and Creasy 1992). 
Resveratrol has been reported to have many functions, 
including SIRT1 activation (Howitz et  al. 2003), anti-
oxidant (Jackson et al. 2011) and anti-inflammation (Sub-
baramaiah et al. 1998) activities.
Interestingly, it has been reported that some polyphe-
nols such as resveratrol and 8-prenylnaringenin are effec-
tive in preventing muscle atrophy caused by disuse or 
aging (Momken et  al. 2011; Mukai et  al. 2012). Moreo-
ver, resveratrol is reported to prevent dexamethasone-
induced increases in protein degradation in cultured 
myotubes (Alamdari et al. 2012). However, the inhibitory 
effects of polyphenols on glucocorticoid-induced muscle 
atrophy in vivo have not been fully elucidated. The aim of 
this study was to examine whether extracts of these poly-
phenol-rich fruits have a protective effect on dexametha-
sone-induced muscle atrophy in aged rats.
Methods
Shiikuwasha and grape extracts
The shiikuwasha and grape extracts were obtained from 
ARKRAY, Inc. Karada Lab (Kyoto, Japan) and Oryza Oil 
& Fat Chemical (Aichi, Japan), respectively. Shiikuwa-
sha extract contains cyclodextrin in order to increase its 
solubility in water. The polyphenols contained in these 
extracts are presented in Table 1.
Animals and treatment
Fifteen-month-old Sprague–Dawley rats were purchased 
from Charles River Japan (Yokohama, Japan). They were 
housed under controlled temperature (21–25 °C), humid-
ity (40–60 %), and lighting (on at 8 a.m. and off at 8 p.m.). 
All animal studies were approved by the Animal Research 
Committee of Morinaga Milk Industry. Following 1 week 
of acclimatization, the rats were divided into 4 groups: 
control (CTL group; n  =  6), dexamethasone (DEX 
group; n =  6), dexamethasone plus shiikuwasha extract 
(DEX + SE group; n = 5), and dexamethasone plus grape 
extract (DEX + GE group; n = 6). Shiikuwasha or grape 
extract was added to the standard AIN-93M rodent diet 
at 1 % by weight. Rats in the DEX + SE and DEX + GE 
groups were fed the diet supplemented with shiikuwa-
sha or grape extract, respectively. CTL and DEX groups 
were fed AIN-93M purified rodent diet. Rats were fed 
each experimental diet for 19 days. To control for varia-
tions in dietary intake in the initial few days, after 1-week 
acclimatization to the experimental diets, dietary intake 
was recorded for the following 12  days. During the last 
5  days of feeding, the DEX, DEX +  SE and DEX +  GE 
Table 1 Composition of shiikuwasha (Citrus depressa Hay-
ata) and grape (Vitis vinifera) extracts
Extract Component Proportion (%)







Other polyphenols About 11.0
Other ingredients About 26.0
Grape extract Resveratrol 5.0
Other polyphenols About 35.0
Other ingredients About 60.0
Page 3 of 8Sakata et al. SpringerPlus  (2016) 5:816 
groups were injected with dexamethasone (750  μg/kg 
B.W.; Fujita Medical, Tokyo, Japan) intraperitoneally once 
per day between 10 and 11 a.m. The dose and treatment 
period of dexamethasone are based on the methods of 
Minet-Quinard et al. (2000). The CTL group was injected 
with an equal volume of saline. Rats in all groups, except 
the CTL group, were provided diet and water ad libitum. 
The CTL group was pair-fed with the DEX group during 
dexamethasone treatment. A day after the last dexameth-
asone treatment, the rats were anesthetized with sevoflu-
rane and sacrificed. Immediately after, blood was taken 
and the hind limb muscles [gastrocnemius, soleus, tibi-
alis anterior (TA), and extensor digitorum longus (EDL)] 
were excised. Blood samples were centrifuged at 1000g 
for 15 min, and sera were collected and stored at −80 °C 
until used in assays. The TA muscle was divided into two 
parts; one part of the TA and the EDL were frozen in liq-
uid nitrogen, and the other part was stored in RNAlater 
(Applied Biosystems, Foster City, CA) at 4  °C overnight 
and then stored at −80  °C until analysis. Gastrocne-
mius muscles were excised, immediately weighed, and 
homogenized with 7 volumes of homogenization buffer 
(20 mM N-2-hydroxyethylpiperazine-N′-2-ethanesulforic 
acid at pH 7.4, 100 mM KCl, 0.2 mM EDTA, 2 mM ethyl-
ene glycol-bis (β-aminoethylether)-N,N,N′,N′,-tetraacetic 
acid, 1  mM dithiothreitol, 50  mM sodium fluoride, 
50  mM β-glycerophosphate, 0.1  mM phenylmethyl sul-
fonyl fluoride, 1 mM benzamidine, and 0.5 mM sodium 
vanadate) using a Polytron homogenizer (Kinematica, 
Littau, Switzerland).
Immunoblotting
The gastrocnemius muscle homogenate was centrifuged 
at 10,000g for 10 min at 4 °C. The supernatant was mixed 
with an equal volume of 2 × SDS sample buffer, and the 
diluted gastrocnemius muscle sample was subjected to 
electrophoresis on a 7.5  % polyacrylamide gel for S6K1 
analysis or a 4–15  % gradient gel (Bio-Rad, Hercules, 
CA) for LC3B and GAPDH analyses. The samples were 
subjected to protein immunoblot analysis using S6K1 
polyclonal antibodies (dilution 1:500, sc-230, Santa Cruz 
Biotechnology, Santa Cruz, CA), LC3B antibody (#2775, 
Cell Signaling Technology, Danvers, MA) or GAPDH 
antibody (#2775, Cell Signaling Technology). The S6K1 
phosphorylation ratio was quantified using the ratio of 
the heavier phosphorylated forms (β + γ forms) to total 
immune reactivity (α  +  β  +  γ forms), because S6K1 
resolves into multiple electrophoretic forms as a result 
of reduced electrophoretic mobility with increased phos-
phorylation, as described previously (Kimball et al. 1998, 
Yoshizawa et al. 2001). The protein content was normal-
ized to GAPDH in the LC3B analysis.
Protein content and TBARS
Protein concentrations of TA muscles were measured 
using the DC protein assay (Bio-Rad). The total protein 
content of each muscle was then calculated by multiply-
ing protein concentration, homogenate volume, and the 
fraction of the ground portion relative to total muscle 
wet weight. TBARS was measured in whole EDL muscle 
homogenate by using the modified methods of Ohkawa 
et al. (1979).
Serum insulin
Serum insulin concentrations were measured using a 
commercial ELISA kit (Morinaga Institute of Biological 
Science, Kanagawa, Japan).
mRNA levels
Total mRNA of TA muscles was extracted with TRI-
zol reagent (Invitrogen, Carlsbad, CA) according to the 
manufacturer’s instructions. The isolated RNA was puri-
fied with an RNeasy mini kit (Qiagen, Dusseldorf, Ger-
many), and its quality was analyzed using the Experion 
system (Bio-Rad). Total RNA was reverse-transcribed 
to cDNA using Taqman reverse transcription reagents 
(Applied Biosystems). Real-time PCR was performed 
with an ABI PRISM 7500 fast real-time PCR system 
(Applied Biosystems). The PCR primers and probes for 
atrogin-1 (Rn00591730), MuRF1 (Rn00590197), IGF-1 
(Rn00710306) and GAPDH (Rn01775763) were pur-
chased from Applied Biosystems. The target gene expres-
sion was normalized to the expression of the control gene 
GAPDH.
Statistical analysis
All values are presented as mean ± SEM. JMP software 
(SAS Institute Inc., Cary, NC) was used for all statistical 
analyses. Results showing significant differences between 
the CTL and DEX groups, according to the Student’s t 
test, were analyzed with Dunnett’s test for multiple com-
parisons between the extract supplemented groups and 
the DEX group. Values of P < 0.05 were considered to be 
statistically significant.
Results
Body weight, dietary intake, and serum insulin
Body weights before dexamethasone treatment were 
not different among the groups (Table  2). During the 
dexamethasone treatment period, dietary intake in 
the DEX group was not different from that in the CTL 
group; however, body weight in the DEX group was sig-
nificantly lower than in the CTL group. Body weight loss 
in both extract-supplemented groups (DEX  +  SE and 
DEX +  GE) was not significantly different from that in 
the DEX group. Hyperinsulinemia was observed in the 
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dexamethasone treated groups. A significant difference 
in serum insulin levels was not observed between either 
of the extract supplemented groups and the DEX group 
(Table 2).
Skeletal muscle weight
The weights of the gastrocnemius, TA and EDL muscles 
were significantly reduced in the DEX group compared to 
the CTL group, while the weight of the soleus muscle was 
not changed (Fig. 1). TA muscle weight in the DEX + SE 
group was markedly higher than in the DEX group 
(Fig. 1b). Similarly, the EDL muscle weight tended to be 
increased in the DEX  +  SE group compared with the 
DEX group; however, this result was not statistically sig-
nificant (P = 0.076; Fig. 1d). Furthermore, there was no 
difference in gastrocnemius muscle weight between the 
DEX group and the DEX + SE group (P = 0.107; Fig. 1a). 
There was no significant difference in the weights of each 
muscle between the DEX and DEX + GE groups.
Muscle protein content
The protein content of the TA muscle in the DEX group 
was lower than in the CTL group (Fig.  2), while that in 
the DEX + SE group was higher than in the DEX group; 
however, this difference was not significant (P = 0.068). 
No difference was observed in protein content between 
the DEX and DEX + GE groups.
Phosphorylation of S6K1 and lipidation of LC3B
The S6K1 phosphorylation ratio, which is calculated by 
dividing β  +  γ forms by total forms, in gastrocnemius 
muscle was markedly lower in the DEX group than in the 
CTL group (Fig.  3). Although S6K1 phosphorylation in 
the DEX + SE group was marginally higher than in the 
DEX group, the difference was not statistically significant 
(P =  0.122). There was no difference in S6K1 phospho-
rylation level between the DEX and DEX + GE groups. 
Both LC3B-I and LC3B-II levels in gastrocnemius mus-
cle were significantly increased by dexamethasone treat-
ment (Fig.  4). Although LC3B-II protein levels in the 
DEX  +  SE and DEX  +  GE groups were slightly lower 
than in the DEX group, the differences were not signifi-
cant (P = 0.163, 0.162 respectively).
mRNA expression
In the TA muscle, atrogin-1 (Fig. 5a) and MuRF1 (Fig. 5b) 
mRNA were significantly increased, while IGF-1 mRNA 
(Fig. 5c) was significantly decreased following dexameth-
asone treatment. Atrogin-1 (Fig. 5a) and MuRF1 (Fig. 5b) 
mRNA expression in the DEX  +  SE group was signifi-
cantly lower than in the DEX group; however, there was 
no difference between the DEX + GE and DEX groups. 
No difference in IGF-1 mRNA expression was detected 
between the DEX group and either of the extract supple-
mented groups (Fig. 5c).
Thiobarbituric acid reactive substances
Muscle oxidative stress was assessed by measuring thio-
barbituric acid reactive substances (TBARS). There were 
no significant differences in TBARS levels among all 
groups (CTL: 1.92 ± 0.43, DEX: 2.13 ± 0.37, DEX + SE: 
2.30  ±  0.48, DEX  +  GE: 1.21  ±  0.09  μmol MDA/g 
protein).
Discussion
In this study, we examined the inhibitory effects of poly-
phenol-rich fruit extracts on skeletal muscle atrophy. 
The supplementation of shiikuwasha extract significantly 
attenuated dexamethasone-induced weight loss in TA 
muscle (P = 0.040) and tended to attenuate weight loss in 
EDL muscle (P = 0.076). To take into account the water 
and fat contents in muscle weight, we measured the pro-
tein content of muscle. The dexamethasone-induced 
decrease in TA protein content tended to be attenuated 
Table 2 Effects of shiikuwasha or grape extract supplementation on dexamethasone-induced changes
Values are mean ± SEM (n = 5 or 6)
CTL control group, DEX dexamethasone treatment group, DEX + SE dexamethasone treatment and shiikuwasha extract supplemented group, DEX + GE 
dexamethasone treatment and grape extract supplemented group
* P < 0.05 CTL versus DEX (student t-test)
CTL DEX DEX + SE DEX + GE
Body weight (g)
 Before DEX treatment 766.5 ± 32.8 757.6 ± 25.1 757.2 ± 20.5 777.0 ± 46.1
 After DEX treatment 735.0 ± 31.9 638.5 ± 20.1* 654.5 ± 19.8 663.5 ± 37.6
Body weight loss (g) 31.57 ± 2.84 119.06 ± 8.68* 102.74 ± 10.66 113.58 ± 10.68
Average dietary intake (g)
 7 days before DEX treatment 22.4 ± 0.30 21.6 ± 0.72 19.4 ± 1.01 20.94 ± 0.51
 5 days during DEX treatment 13.1 ± 0.14 11.52 ± 0.91 9.33 ± 0.86 11.14 ± 1.12
Serum insulin (ng/ml) 0.56 ± 0.13 12.03 ± 2.54* 8.42 ± 1.42 14.06 ± 2.98
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by the diet supplemented with shiikuwasha extract 
(P  =  0.068). Grape extract, on the other hand, did not 
have any noteworthy effect on muscle atrophy.
The catabolic action of glucocorticoids on skeletal mus-



































































Fig. 1 Effect of shiikuwasha extract or grape extract supplementation on dexamethasone-induced changes in hind-limb muscle weight. Rats were 
fed an extract-supplemented diet for 19 days. During the last 5 days of feeding, the DEX, DEX + SE and DEX + GE groups were injected with dexa-
methasone, while the CTL group was injected with an equal volume of saline. After 5 days of dexamethasone treatment, hind-limb muscles were 
collected and weighed. a Gastrocnemius muscle, b tibialis anterior muscle, c soleus muscle, d extensor digitorum longus muscle. CTL control, DEX 
dexamethasone, DEX + SE dexamethasone + shiikuwasha extract, DEX + GE dexamethasone + grape extract. Values are mean ± SEM (n = 5 or 6). 






















Fig. 2 Effect of shiikuwasha extract or grape extract supplementa-
tion on dexamethasone-induced changes in protein content. Protein 
content of TA muscles was determined using the DC protein assay. 
CTL control, DEX dexamethasone, DEX + SE dexamethasone + shiiku-
washa extract, DEX + GE dexamethasone + grape extract. Values are 

































Fig. 3 Effect of shiikuwasha extract or grape extract supplementa-
tion on dexamethasone-induced changes in S6K1 phosphorylation. 
Phosphorylation of S6K1 in gastrocnemius muscle was expressed as 
the amount of S6K1 in the β and γ forms as percentage of total S6K1. 
CTL control, DEX dexamethasone, DEX + SE dexamethasone + shiiku-
washa extract, DEX + GE dexamethasone + grape extract. Values are 
mean ± SEM (n = 5 or 6). *P < 0.05 CTL versus DEX (student’s t-test)
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pathways, in particular the ubiquitin–proteasome sys-
tem and the autophagy-lysosomal system. It has been 
reported that glucocorticoids activate FOXO and KLF15 
expression via the glucocorticoid receptor (GR) (Shimizu 
et  al. 2011). These proteins promote gene expression of 
atrophy-stimulating genes such as atrogin-1 and MuRF1. 
In the present study, the supplementation of shiikuwa-
sha extract reduced dexamethasone-induced increases 
in atrogin-1 and MuRF1 mRNA expression. Although 
we did not examine the effects of shiikuwasha extract on 
FOXO and KLF15, it is possible that shiikuwasha extract 
also inhibits the expression and/or activation of these fac-
tors. Penna et al. reported that dexamethasone treatment 
elevated LC3B-I and LC3B-II protein levels and reduced 
P62/SQSTM1 levels in young mice (Penna et al. 2013). In 
this study, LC3B-I and LC3B-II were increased similarly 
by dexamethasone treatment. It has been suggested that 
autophagy is activated by dexamethasone administration. 
However, the supplementation of shiikuwasha extract 
did not reduce LCB3-I and LC3B-II protein levels. These 
results indicate that shiikuwasha extract may inhibit the 
elevation of the ubiquitin–proteasome system but does 
not affect the autophagy-lysosomal system in glucocorti-
coid-induced muscle atrophy.
Glucocorticoids also inhibit muscle protein synthe-
sis. Phosphorylation of S6K1 and eIF4E-binding protein 
1 (4E-BP1) are inhibited by glucocorticoids via blunting 
of anabolic stimuli such as insulin, insulin-like growth 
factor-I (IGF-I), and amino acids (leucine) (Shah et  al. 
2000a, b; Liu et al. 2001, 2004). In the present study, S6K1 
phosphorylation was significantly reduced by dexameth-
asone treatment. The supplementation of shiikuwasha 
extract slightly attenuated the inhibition of S6K1 phos-
phorylation, while the supplementation of grape extract 
had no effect. In addition, IGF-1 mRNA expression was 
significantly reduced by dexamethasone treatment. Nei-
ther extract had any effect on IGF-1 mRNA expression. 
There are a few reports concerning the influence of nobi-
letin on protein synthesis. Lee et al. reported that nobi-
letin upregulates Akt phosphorylation in diabetic ob/
ob mice (Lee et al. 2010). This result suggests that poly-
methoxylated flavones improve protein synthesis under 
certain catabolic conditions, such as diabetes mellitus. 
Similarly, shiikuwasha extract may also have a positive 
effect on mTOR signaling and protein synthesis.
Glucocorticoid excess induces acute insulin resistance 
(Pagano et al. 1983) and increases oxidative stress (Iuchi 
et  al. 2003). Antioxidant vitamins C and E have been 
reported to improve glucocorticoid-induced glucose 
intolerance (Williams et al. 2012). Furthermore, vitamin 
E attenuates oxidative stress and skeletal muscle atrophy 
induced by glucocorticoids (Ohtsuka et  al. 1998). One 
possible mechanism of these beneficial effects of vita-
mins E and C could be due to a reduction in glucocorti-
coid-induced oxidative stress. In this study, serum insulin 
was increased by dexamethasone, however TBARS in 
the EDL muscle was not increased. The reason why an 
increase in the TBARS level was not observed is prob-
ably due to the elevation of TBARS with increasing age. 
Furthermore, dietary supplementation with either shii-












































Fig. 4 Effect of shiikuwasha extract or grape extract supplementa-
tion on dexamethasone-induced changes in LC3B-I and LC3B-II. 
Both LC3B-I and LC3B-II protein levels in gastrocnemius muscle were 
normalized to GAPDH. a LC3B-I normalized to GAPDH, b LC3B-II 
normalized to GAPDH. CTL control, DEX dexamethasone, DEX + SE 
dexamethasone + shiikuwasha extract, DEX + GE dexametha-
sone + grape extract. Values are mean ± SEM (n = 5 or 6). *P < 0.05 
CTL versus DEX (student’s t-test)
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levels of TBARS and serum insulin. Decreased oxidative 
stress and increased endogenous anti-oxidative enzymes 
associated with the intake of polyphenols are suggested 
as plausible mechanisms by which polyphenols attenu-
ate skeletal muscle atrophy. In particular, it has been 
indicated that resveratrol, via a pathway that involves 
the activation of SIRT1 and the up-regulation of antioxi-
dant defense mechanisms (Ungvari et  al. 2009), attenu-
ates oxidative stress in aged skeletal muscle (Jackson 
et  al. 2011). While an effect of dietary supplementation 
with shiikuwasha on TBARS levels was not observed in 
the present study, the possibility that shiikuwasha extract 
has an inhibitory effect on oxidative stress, and that this 
effect is involved in the attenuation of skeletal muscle 
atrophy, cannot be discounted. This contention is sup-
ported by the fact that shiikuwasha extract contains nobi-
letin, which has antioxidative activity (Lu et al. 2010), and 
by the observation that an increase in oxidative stress in 
response to dexamethasone was not observed in the pre-
sent study. Many studies have provided evidence of the 
inhibitory effects of resveratrol on muscle atrophy in var-
ious animal models, such as disuse (Jackson et al. 2010), 
diabetes (Chen et  al. 2011), and cancer cachexia (Shad-
far et  al. 2011). In addition, resveratrol inhibited dexa-
methasone-induced protein degradation in L6 myotubes 
(Alamdari et al. 2012); however, a grape extract contain-
ing resveratrol had no effect on skeletal muscle atrophy 
in the present study. Shadfar et al. suggested that a res-
veratrol dose of at least 200 mg/kg/day might be neces-
sary to prevent cancer cachexia-induced muscle atrophy 
(Shadfar et  al. 2011). The dose of grape extract used in 
this study may be insufficient to prevent glucocorticoid-
induced muscle atrophy.
Neither the inhibitory effect of shiikuwasha extract nor 
that of polymethoxylated flavones in shiikuwasha fruit on 
muscle atrophy has been reported. In addition, there are 
few reports on the effects of this extract or polymethoxy-
lated flavones on either protein synthesis or degradation. 
Further studies are needed to elucidate the mechanisms 
of the inhibitory effects of shiikuwasha extract on mus-
cle atrophy. It is also necessary to determine the effect 
of shiikuwasha extract on muscle atrophy resulting from 
other causes such as disuse.
Conclusions
We found that shiikuwasha extract attenuated dexa-
methasone-induced skeletal muscle atrophy in aged 
rats. Although the exact mechanism has not been fully 
defined, shiikuwasha extract may partially inhibit the 
activation of the ubiquitin–proteasome system and may 
consequently attenuate skeletal muscle atrophy induced 
by dexamethasone in aged rats. Our findings indicate 
that shiikuwasha extract could be useful for attenuating 
muscle atrophy associated with increases in circulat-
ing glucocorticoid levels, such as in sepsis, cachexia, and 
starvation.
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Fig. 5 Effect of shiikuwasha extract or grape extract supplementation on dexamethasone-induced changes in mRNA expression. The mRNA was 
extracted from tibialis anterior muscles and measured using RT-PCR. The mRNA expression was normalized to GAPDH. a Atrogin-1 mRNA expres-
sion, b MuRF1 mRNA expression, c IGF-1 mRNA expression. CTL control, DEX dexamethasone, DEX + SE dexamethasone + shiikuwasha extract, 
DEX + GE dexamethasone + grape extract. Values are mean ± SEM (n = 5 or 6). *P < 0.05 CTL versus DEX (student’s t-test), †P < 0.05 versus DEX 
(Dunnett’s test)
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